|
CDCA3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.9475983006414E-14 |
| Normal-vs-Stage2 |
2.4185000000454E-06 |
| Normal-vs-Stage3 |
1.48849998993228E-09 |
| Normal-vs-Stage4 |
2.059699999446E-07 |
| Stage1-vs-Stage2 |
9.639600E-01 |
| Stage1-vs-Stage3 |
2.203700E-03 |
| Stage1-vs-Stage4 |
1.169810E-04 |
| Stage2-vs-Stage3 |
5.999600E-03 |
| Stage2-vs-Stage4 |
1.444990E-04 |
| Stage3-vs-Stage4 |
1.473900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.768430E-04 |
| Normal-vs-Asian |
9.269500E-02 |
| Caucasian-vs-AfricanAmerican |
6.192000E-02 |
| Caucasian-vs-Asian |
3.318600E-01 |
| AfricanAmerican-vs-Asian |
2.218400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62891922173003E-12 |
| Normal-vs-Female |
1.65012448150037E-12 |
| Male-vs-Female |
9.359700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.880800E-03 |
| Normal-vs-Age(41-60Yrs) |
9.34390342877123E-11 |
| Normal-vs-Age(61-80Yrs) |
1.73594472130389E-12 |
| Normal-vs-Age(81-100Yrs) |
1.042030E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.769630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.375400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.728840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.705200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.819800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.311200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.497600E-02 |
| Normal-vs-Grade 2 |
5.83977310952832E-14 |
| Normal-vs-Grade 3 |
2.56428211997672E-12 |
| Normal-vs-Grade 4 |
7.49689999968162E-07 |
| Grade 1-vs-Grade 2 |
9.924400E-03 |
| Grade 1-vs-Grade 3 |
1.57076999999228E-05 |
| Grade 1-vs-Grade 4 |
2.44079999999203E-05 |
| Grade 2-vs-Grade 3 |
1.460410E-03 |
| Grade 2-vs-Grade 4 |
2.551700E-04 |
| Grade 3-vs-Grade 4 |
7.604400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.65698574253292E-12 |
| Normal-vs-ccB subtype |
2.93449708976823E-11 |
| ccA subtype-vs-ccB subtype |
3.08370000001723E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.99214036564899E-12 |
| Normal-vs-N1 |
1.039310E-03 |
| N0-vs-N1 |
1.428330E-02 |
|
|
